DyneLogo_R_FINAL_FULL_COLOR_RGB.jpg
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
May 21, 2024 20:39 ET | Dyne Therapeutics, Inc.
WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for...
Checkpoint Therapeutics, Inc. Class Action
June 4th Lead Plaintiff Deadline Approaching in Class Action Against Checkpoint Therapeutics, Inc. – Contact Robbins LLP Today
May 21, 2024 20:05 ET | Robbins LLP
Robbins LLP is Investigating the Allegations that Checkpoint Therapeutics, Inc. Overstated the Prospects of its Lead Product Candidate, Cosibelimab
Globe Life, Inc.  Class Action Lawsuit
Globe Life, Inc. Class Action Notification: Contact Robbins LLP for Information About Your Rights Against GL
May 21, 2024 20:02 ET | Robbins LLP
Robbins LLP is Investigating the Allegations that Globe Life, Inc. (GL) Engaged in Insurance Fraud
APRINOIA Therapeutic
APRINOIA Therapeutics宣布APN-1607获得美国FDA授予快速通道认定用于诊断进行性核上性麻痹
May 21, 2024 20:00 ET | APRINOIA Therapeutics, Inc.
马萨诸塞州剑桥, May 22, 2024 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics Inc.(“APRINOIA”或“公司”),专注于开发神经退行性疾病的新颖治疗和精确诊断方法的临床阶段生物制药公司,今天宣布,美国食品药品监督管理局(FDA)于2024年5月月8日授予正电子发射断层扫描(PET)示踪剂APN-1607(florzolotau...
APRINOIA Therapeutic
APRINOIA Therapeutics進行性核上性麻痺の診断薬APN-1607の 米国FDAによるファストトラック指定を発表
May 21, 2024 20:00 ET | APRINOIA Therapeutics, Inc.
マサチューセッツ州ケンブリッジ , May 22, 2024 (GLOBE NEWSWIRE) --...
APRINOIA Therapeutic
APRINOIA Therapeutics宣佈APN-1607獲得美國FDA授予快速審查認定用於診斷進行性核上性麻痹
May 21, 2024 20:00 ET | APRINOIA Therapeutics, Inc.
麻塞諸塞州劍橋, May 22, 2024 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics Inc.(“APRINOIA”或“公司”),以開發神經退行性疾病的新穎治療和精確診斷方法為主的臨床階段生物製藥公司,今天宣佈,美國食品藥品監督管理局(FDA)於2024年5月月8日授予正電子發射斷層掃描(PET)示蹤劑APN-1607(florzolotau...
APRI Logo.png
APRINOIA Therapeutics Announces Fast Track Designation Granted by U.S. FDA to APN-1607 for the Diagnosis of Progressive Supranuclear Palsy
May 21, 2024 20:00 ET | APRINOIA Therapeutics, Inc.
CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- APRINOIA Therapeutics Inc. (“APRINOIA” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics and precision...
MnM_logo_TM_JPG.JPG
Agriculture Industry Poised for Significant Growth in 2024, Driven by Innovation and Sustainability
May 21, 2024 20:00 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 21, 2024 (GLOBE NEWSWIRE) -- Market to Reach $94.3 Billion by Year-End, up 15.7% Year-over-Year According to a research report “Global Agriculture Industry Outlook 2024 - Feeding...
MnM_logo_TM_JPG.JPG
Industrial Robotics Market - Demand, Growth, and Industry Analysis [2028]
May 21, 2024 19:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 21, 2024 (GLOBE NEWSWIRE) -- The Industrial Robotics Market is valued at USD 17.0 billion in 2023 and is projected to reach USD 32.5 billion by 2028, growing at a CAGR of 13.8% from...
Verisk Hi Res Logo.png
Verisk Analytics, Inc. Prices Offering of Senior Notes
May 21, 2024 19:21 ET | Verisk Analytics, Inc.
JERSEY CITY, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Verisk Analytics, Inc. (Nasdaq: VRSK) (“Verisk” or the “Company”), a leading global data analytics and technology provider, today announced the...